Subcutaneous natalizumab administration in relapsing-remitting multiple sclerosis: results of EASIER 2 study. Filippi M, Grimaldi LME, Brescia Morra V, Conte A, et al. J Neurol 2026;273:452.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Filippi M, Grimaldi LME, Brescia Morra V, Conte A, et al. Subcutaneous natalizumab administration in relapsing-remitting multiple sclerosis: results of EASIER 2 study. J Neurol 2026;273:452.
PMID: 42429976